Toy Parrot Improves Mood and Behavior in Alzheimer's Patient
This article is about Alzheimer's disease,Pete the Repeat Parrot, and my mother Dotty who lived with Alzheimer's disease.He might not look like much in the image (see image at the bottom of this article); but he is powerful and will provide you with hours of stress free respite. Most caregivers assume this parrot won't work for them. In almost every case, over 900 caregivers, it worked. You might pay about $20 for one hour of respite care. You can buy this parrot for around $20. By my own estimate this parrot provided me with about 3,000 hours of respite care at a cost of less thanone cent (.006) per hour.By Bob DeMarcoAlzheimer's Reading RoomI'll start by mentioning, I tried to determine if their was any other variable that could be causing the behavior and mood improvement in my mother. As far as I could tell, the only thing that changed was the purposeful introduction of Pete the Repeat Parrot into our lives.For those of you that know me from this blog, you know that I was always trying to do things that improved my mother's behavior and interaction with others and me.For the most part, everything I tried came from simple observations, or from something that I read and then reconnoitered to make it work in an Alzheimer's filled environment.In the case of Pete the Parrot is was part design but mostly luck.Please read this article also -The Best Alzheimer's Caregiver Tool of Them All, HarveyMy mother loved greeting cards that sang and/or shook. We had the...
THE FIRST human trials of a ground-breaking drug shown to repair DNA damage that contributes to Alzheimer ’s disease will be launched this week, in a move scientists hope could lead to a cure. The study, being launched in the UK, and hospitals in France and Spain, will, for the first time, see the neuro-degenerative condition treated with an agent which acts as a DNA repair kit to restore memory and r everse behavioural changes such as aggression and social avoidance.
DISCUSSION: PET can evaluate amyloid expansion from cortex to subcortex. Using striatal signal as a marker of advanced amyloidosis may increase predictive power in Alzheimer's dementia research. PMID: 29792874 [PubMed - as supplied by publisher]
DISCUSSION: Distinct classes of cognitive trajectories were associated with risk and protective factors of AD. These associations support the notion that the identified cognitive trajectories reflect different risk for AD that may be useful for selecting high-risk individuals for intervention trials. PMID: 29792873 [PubMed - as supplied by publisher]
DISCUSSION: GBA variants are of great clinical relevance for the development of dementia in Parkinson's disease, especially due to the relatively higher frequency of these alleles compared with other risk alleles. PMID: 29792872 [PubMed - as supplied by publisher]
DISCUSSION: White matter hyperintensities are associated with an increased risk of all-dementia and Alzheimer's disease in the general population. However, studies are warranted to further determine the role of markers of cerebral small vessel disease in dementia. PMID: 29792871 [PubMed - as supplied by publisher]
DISCUSSION: SNP effects on erythrocyte CR1 likely underlie the association of CR1 polymorphisms with AD risk. PMID: 29792870 [PubMed - as supplied by publisher]
DEMENTIA is a term used to describe different types of brain degeneration. The most common type of dementia is Alzheimer ’s Disease, although vascular dementia and dementia with lewy bodies are also types. Symptoms of dementia include leaving items in the wrong place and memory loss. New research has provided hope for diagnosing dementia early, by finding that people with more yellow spots in their eye are more like ly to have the condition.
Objectives: This analysis assessed the safety of intravenous immunoglobulin (IVIg) in the treatment of patients with neuroimmunological and immunological disorders in a home-based setting. Methods: Adverse reactions (ARs) were assessed in a retrospective review of 1176 patients receiving 28,677 home-based IVIg infusions between 1996 and 2013. Results: Of 1176 patients, 648 (55.1%) experienced IVIg-related ARs; 536 (45.6%) were mild, 78 (6.6%) moderate, and 34 (2.9%) severe. Thirty-seven (3.1%) patients were hospitalized because of ARs; of these, headache was most common (51.4%). Mean number of ARs per patient incre...
HIGH blood pressure symptoms include headaches, chest pain and difficult breathing. Making this takeaway diet swap could make your Indian or Chinese meal more healthy, and lower your risk of hypertension.
Alzheimer's caregivers often confuse the difference between short term memory loss and memories.Dementia patients lose their ability to remember new information and experiences. This happens because they can no longer store new memories in their brain.On the other hand,dementia patients remain full of memories. These memories were stored in their brain long before the onset of Alzheimer's disease.Topic -How to Reduce Caregiver StressBy Bob DeMarcoAlzheimer's Reading RoomSubscribe to the Alzheimer's Reading RoomEmail:A simple example. My mother was already in the moderate to severe stages of dementia. One night while we wer...